ED Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Consolidated Edison Inc (ED) is not a strong buy for a beginner, long-term investor at this time. While the stock has defensive qualities as a utility and hedge funds are increasing their positions, the lack of significant growth catalysts, declining financial metrics, and mixed analyst sentiment suggest holding rather than buying. The current technical indicators also do not strongly support an immediate entry point.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 42.448, suggesting no clear signal. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below its pivot level of 111.515, with key support at 109.628. Overall, the technical indicators are mixed, leaning slightly bearish.
Hedge funds are increasing their positions, with a 108.15% rise in buying activity over the last quarter.
Utility stocks, including ED, are considered defensive plays during market volatility and global conflicts.
The utilities sector has historically outperformed the S&P 500 during recessions and conflicts.
Financial performance in Q4 2025 showed declining net income (-4.19% YoY), EPS (-7.87% YoY), and gross margin (-1.65% YoY).
Analysts have mixed ratings, with several maintaining Underweight or Neutral views, citing limited growth catalysts and elevated financing needs.
The stock's price is down 1.58% in regular trading and is trading below its pivot level, indicating weak short-term momentum.
In Q4 2025, revenue increased by 8.86% YoY to $3.994 billion. However, net income dropped by 4.19% YoY to $297 million, EPS declined by 7.87% YoY to $0.82, and gross margin decreased by 1.65% YoY to 60.34%. These metrics indicate some revenue growth but declining profitability.
Analysts have mixed views. Positive ratings include Citi raising the price target to $130 with a Buy rating and Mizuho raising the target to $118 with an Outperform rating. However, multiple firms, including KeyBanc, BofA, and Barclays, maintain Underweight or Neutral ratings, citing limited growth catalysts and elevated financing needs. The price targets range from $96 to $130, with a median target near $112, close to the current price.
